Literature DB >> 12770941

Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.

Christopher W Vaughan1, Elena E Bagley, Geoffrey M Drew, Alwin Schuller, John E Pintar, Stephen P Hack, MacDonald J Christie.   

Abstract

1 Patch clamp recordings were made from periaqueductal grey (PAG) neurons in vitro to investigate the cellular actions of opioids in wild-type C57B16/J mice and mutant mice lacking the first exon of the micro -opioid (MOP) receptor. 2 In wild-type mice, the kappa-(KOP) agonist U-69593 (300 nM) and the mixed micro /delta-opioid agonist met-enkephalin (10 micro M), but not the delta-(DOP) agonist deltorphin (300 nM), reduced the amplitude of evoked GABA(A)-mediated inhibitory postsynaptic currents (IPSCs). Met-enkephalin and U-69593 also reduced the rate of spontaneous miniature IPSCs, but had no effect on their amplitude and kinetics. In micro -receptor-deleted mice, only U-69593 (300 nM) reduced the amplitude of evoked IPSCs. 3 In wild-type mice, the MOP agonist DAMGO (3 micro M) produced an outward current in 76% of the neurons. Deltorphin and U-69593 produced outward currents in 24 and 32% of the neurons, respectively. In micro -receptor-deleted mice, deltorphin and U-69593 produced similar outward currents in 32 and 27% of the neurons, respectively, while DAMGO was without effect. All neurons in both the wild-type and micro -receptor-deleted mice responded with similar outward currents to either the GABA(B) receptor agonist baclofen (10 micro M), or the opioid-like receptor ORL1 (NOP) agonist nociceptin (300 nM). 4 The DAMGO-, deltorphin-, U-69593-, baclofen- and nociceptin-induced currents displayed inward rectification and reversed polarity at -109 to -116 mV. 5 These findings indicate that micro -, delta- and kappa-opioid receptor activation has complex pre- and postsynaptic actions within the mouse PAG. This differs to the rat PAG where only micro -opioid receptor actions have been observed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770941      PMCID: PMC1573857          DOI: 10.1038/sj.bjp.0705261

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist.

Authors:  Michael A Ackley; Robert W Hurley; Daniel E Virnich; Donna L Hammond
Journal:  Pain       Date:  2001-04       Impact factor: 6.961

Review 2.  Neurotransmitters in nociceptive modulatory circuits.

Authors:  H L Fields; M M Heinricher; P Mason
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

3.  Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons.

Authors:  K R Svoboda; C E Adams; C R Lupica
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

4.  mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality.

Authors:  H H Loh; H C Liu; A Cavalli; W Yang; Y F Chen; L N Wei
Journal:  Brain Res Mol Brain Res       Date:  1998-03-01

5.  Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.

Authors:  C W Vaughan; M Connor; E E Bagley; M J Christie
Journal:  Mol Pharmacol       Date:  2000-02       Impact factor: 4.436

6.  Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell.

Authors:  G O Hjelmstad; H L Fields
Journal:  J Neurophysiol       Date:  2001-03       Impact factor: 2.714

7.  Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of mu-, delta- or kappa-opioid receptor knockout mice.

Authors:  S J Slowe; S Clarke; I Lena; R J Goody; R Lattanzi; L Negri; F Simonin; H W Matthes; D Filliol; B L Kieffer; I Kitchen
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

8.  Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.

Authors:  A G Schuller; M A King; J Zhang; E Bolan; Y X Pan; D J Morgan; A Chang; M E Czick; E M Unterwald; G W Pasternak; J E Pintar
Journal:  Nat Neurosci       Date:  1999-02       Impact factor: 24.884

9.  Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.

Authors:  M Connor; A Schuller; J E Pintar; M J Christie
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 10.  Exploring the opioid system by gene knockout.

Authors:  Brigitte L Kieffer; Claire Gavériaux-Ruff
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

View more
  18 in total

1.  Spatiotemporal control of opioid signaling and behavior.

Authors:  Edward R Siuda; Bryan A Copits; Martin J Schmidt; Madison A Baird; Ream Al-Hasani; William J Planer; Samuel C Funderburk; Jordan G McCall; Robert W Gereau; Michael R Bruchas
Journal:  Neuron       Date:  2015-04-30       Impact factor: 17.173

2.  The effect of gp120 on morphine's antinociceptive and neurophysiological actions.

Authors:  Xiaohong Chen; Lynn G Kirby; Jonathan Palma; Khalid Benamar; Ellen B Geller; Toby K Eisenstein; Martin W Adler
Journal:  Brain Behav Immun       Date:  2011-05-05       Impact factor: 7.217

Review 3.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

Review 4.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 5.  Endogenous opioid peptides in the descending pain modulatory circuit.

Authors:  Elena E Bagley; Susan L Ingram
Journal:  Neuropharmacology       Date:  2020-05-15       Impact factor: 5.250

6.  Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway.

Authors:  Benjamin K Lau; Bryony L Winters; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

7.  Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.

Authors:  Stephen P Hack; Elena E Bagley; Billy C H Chieng; MacDonald J Christie
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

8.  Periaqueductal Gray and Rostromedial Tegmental Inhibitory Afferents to VTA Have Distinct Synaptic Plasticity and Opiate Sensitivity.

Authors:  Robyn St Laurent; Valentina Martinez Damonte; Ayumi C Tsuda; Julie A Kauer
Journal:  Neuron       Date:  2020-03-18       Impact factor: 17.173

9.  Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia.

Authors:  Enrica Bianchi; Monica Norcini; Alan Smrcka; Carla Ghelardini
Journal:  J Neurochem       Date:  2009-07-27       Impact factor: 5.372

Review 10.  Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Authors:  Courtney L Donica; Hibah O Awwad; Deepak R Thakker; Kelly M Standifer
Journal:  Mol Pharmacol       Date:  2013-02-08       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.